share_log

Shareholder Alert: Ademi LLP Investigates Whether Taro Pharmaceutical Industries Limited Has Obtained a Fair Price for Its Public Shareholders in Its Transaction With Its Majority Shareholder, Sun Pharmaceutical Industries Limited.

Shareholder Alert: Ademi LLP Investigates Whether Taro Pharmaceutical Industries Limited Has Obtained a Fair Price for Its Public Shareholders in Its Transaction With Its Majority Shareholder, Sun Pharmaceutical Industries Limited.

股東提醒:Ademi LLP正在調查太郎製藥工業有限公司在與其大股東太陽製藥工業有限公司的交易中是否爲其公衆股東獲得了公平的價格。
PR Newswire ·  05/21 03:10

MILWAUKEE, May 20, 2024 /PRNewswire/ -- Ademi LLP is investigating Taro (NYSE: TARO) for possible breaches of fiduciary duty and other violations of law in its transaction with its majority shareholder Sun.

密爾沃基,2024年5月20日 /PRNewswire/ — Ademi LLP正在調查Taro(紐約證券交易所代碼:TARO)在與大股東太陽的交易中可能違反信託義務和其他違法行爲

Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

點擊此處了解如何加入或撥打 Guri Ademi 的免費電話 866-264-3995。您無需支付任何費用或承擔任何義務。

In the transaction, Taro's stockholders receive $43.00 in cash for each share of Taro common stock they own. Taro insiders receive substantial benefits as part of change of control arrangements and Taro's board is not likely to have been independent in its negotiation of the transaction given Sun's majority position.

在交易中,Taro的股東每持有Taro普通股可獲得43.00美元的現金。作爲控制權變更安排的一部分,太郎內部人士獲得了可觀的收益,鑑於孫的多數地位,太郎董事會在交易談判中不太可能保持獨立。

We are investigating the conduct of Taro's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

我們正在調查太郎董事會的行爲,以及他們是否履行了對所有股東的信託責任。

If you own Taro common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or

如果你擁有太郎普通股並希望獲得更多信息,請致電 [email protected] 或免費電話:866-264-3995 與 Guri Ademi 聯繫,或

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

我們專門處理涉及收購、合併和全國各地個人股東權利的股東訴訟。欲了解更多信息,請隨時致電我們。律師廣告。先前的結果並不能保證類似的結果。

Contacts

聯繫人

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Ademi LLP
Guri Ademi
免費電話:(866) 264-3995
傳真:(414) 482-8001

SOURCE Ademi LLP

來源 Ademi LLP

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論